Mateon Completes Its Acquisition of PointR Data Inc. - DATAVERSITY
Keeping an eye on Mateon Therapeutics (OTCQB: MATN) says GEN - Genetic Engineering & Biotechnology News - EmergingGrowth.com
Mateon Halts Lead Candidate Development, Axes 60% of Workforce
MATN: Positive Early Results for ARTIVeda™ in Treating COVID-19…
Mateon Therapeutics
Corporate Videos – Oncotelic
Mateon | HealthWire
Windlas Biotech, Mateon Therapeutics launch integrated solution for respiratory wellness in India
Windlas Biotech, Mateon Therapeutics bring lung therapy food supplement PulmoHeal - FFOODS Spectrum - Unleashing the Power of Food Science & Technology
Mateon Therapeutics Announces Termination of FOCUS Study in
Mateon Therapeutics Archives - IndiaMedToday
NantCell Binding Termsheet | MATEON THERAPEUTICS INC | Business Contracts | Justia
Dr. Anthony E. Maida will be presenting at the Marcus Evans Evolution Summit
EX-4.1
Zacks Small-Cap Research
Mateon and PointR to merge into AI-driven oncology firm
Windlas Biotech, Mateon Therapeutics launch drug-device plus lung therapy platform - Express Pharma
Mateon launches antiviral programme focussed on Covid-19
COVID Pandemic Hastens Search For New Technology And CRO Partner
Mateon Therapeutics
Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 - OT-101 – Blockchain News, Opinion, TV and Jobs
Windlas Biotech and Mateon Therapeutics to launch combined lung therapy, AI Telemedicine solution - Express Healthcare
A Covid-19 treatment plan slowly emerges | Evaluate
Joint Venture Agreement relating to GMP Biotechnology Limited | MATEON THERAPEUTICS INC | Business Contracts | Justia
iBio Announces Collaboration with EdgePoint AI for Next Gen Biologics Manufacturing - DATAVERSITY
Articles about Mateon Therapeutics, Inc.
